Sartorius T-Cell Autologous Manufacturing Solution
Functionally closed solution to manufacture and rapidly release consistent, high-quality autologous CAR-T cells
Control strategy: Develop and enact a manufacturing control strategy with advanced, sensitive expansion monitoring and control, consistent serum-free, xeno-free T-cell medium, gentle harvesting, and 3-hour PCR-based sterility testing
Automation: Streamline CAR-T production with integrated DCU for real-time monitoring of cell growth throughout expansion with substrate addition via multiple controllers
Remote manufacturing: Gain real-time process insight for possible manufacturing trajectory correction with Sartorius multivariate prediction technology
Assured supply: Maintain consistently high CAR-T cell product quality with low-E&L consumables manufactured under complete control of single-use supply chain and with long-term business continuity
4Cell® Nutri-T
Xeno-free, serum-free medium specifically designed for the culture and expansion of lymphocytes